The week in review

recall regulatory

We take a look back at the week in pharmacy

Over the weekend, Valium 5mg in blister packs of 50 tablets was recalled due to tampering, in a case which was referred to NSW Police: in some packs they’d been replaced by BTC paracetamol codeine tablets, BTC rosuvastatin 10mg tablets and Apotex-Pantoprazole 40mg and 20mg tablets. These were also recalled, and later joined by a batch of Sanofi-Aventis’ Stemetil 5mg.

After an internal investigation Symbion dismissed an employee over alleged theft and tampering. Several AJP readers expressed frustration at the way the Valium recall was handled, with one Auspharm forum member writing, “why did I have customers bringing back Valium for a refund before anything had been communicated to the Pharmacy about the recall?”

Australia Greens leader Senator Richard Di Natale questioned whether compensating pharmacists for the shortfall in script incomes was an appropriate use of public funds; while Health Department officials admitted that the $200 million compensation would not cover the shortfall.

There was good news this week: The Pharmacy Practitioner Development Committee released the national competency standards framework for pharmacists, and Health Minister Greg Hunt pledged more funding to combat antimicrobial resistance. The Minister also told the AMA conference that pharmacy is one of the “four pillars” of health care.

Discount Drug Stores announced a raft of new initiatives including partnerships with FRED NXT and MedAdvisor, as well as pain clinics and a health food and organics project. DDS also named its top performers for the year, as did the Malouf group: congratulations to all!

And talking of winners, AJP wants to know who you think are the up-and-coming stars of the profession. Vote here!

Previous Clinical tips: incontinence
Next A hard act to follow

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.

No Comment

Leave a reply